Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study

PURPOSE: Metformin is a commonly used medication for type II diabetes mellitus. Epidemiologic studies have suggested a decreased relative risk of cancer with metformin use, and preclinical studies of prostate cancer (PCa) have shown antitumor activity with metformin. In this study, we explore the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Jonathan L., Stanford, Janet L.
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2009
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767519/
https://www.ncbi.nlm.nih.gov/pubmed/19653109
http://dx.doi.org/10.1007/s10552-009-9407-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767519/
https://www.ncbi.nlm.nih.gov/pubmed/19653109
http://dx.doi.org/10.1007/s10552-009-9407-y

Ejemplares similares